Circulating adrenomedullin mRNA is decreased in women destined to develop term preeclampsia

Duley, 2009, The global impact of pre-eclampsia and eclampsia, Semin. Perinatol., 33, 130, 10.1053/j.semperi.2009.02.010 Lyall, 2013, Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome, Hypertension, 62, 1046, 10.1161/HYPERTENSIONAHA.113.01892 Clark, 1998, A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation, Biol. Reprod., 59, 1540, 10.1095/biolreprod59.6.1540 Krauss, 2004, Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia, Hypertens. Pregnancy, 23, 101, 10.1081/PRG-120028286 Grill, 2009, Potential markers of preeclampsia – a review, Reprod. Biol. Endocrinol., 7, 70, 10.1186/1477-7827-7-70 Barker, 1997 Morgenthaler, 2005, Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay, Clin. Chem., 51, 1823, 10.1373/clinchem.2005.051110 Guignant, 2009, Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients, Intensive Care Med., 35, 1859, 10.1007/s00134-009-1610-5 Paiva, 2011, Measurement of mRNA transcripts of very high placental expression in maternal blood as biomarkers of preeclampsia, J. Clin. Endocrinol. Metab., 96, E1807, 10.1210/jc.2011-1233 Raymond, 2011, A critical review of early-onset and late-onset preeclampsia, Obstet. Gynecol. Surv., 66, 497, 10.1097/OGX.0b013e3182331028 Phillips, 2010, Evidence for distinct preterm and term phenotypes of preeclampsia, J. Maternal-Fetal Neonatal Med., 23, 622, 10.3109/14767050903258746 Practice ACoO, ACOG Practice Bulletin, Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists, Int. J. Gynaecol. Obstet. 77(1) (2002) 67. Burton, 2014, Optimising sample collection for placental research, Placenta, 35, 9, 10.1016/j.placenta.2013.11.005 Brownfoot, 2015, Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia, Hypertension, 66, 687, 10.1161/HYPERTENSIONAHA.115.05445 Kaitu'u-Lino, 2014, Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin, Pregnancy Hypertens., 4, 287, 10.1016/j.preghy.2014.09.003 Karumanchi, 2004, Hypoxia and sFlt-1 in preeclampsia: the “chicken-and-egg” question, Endocrinology, 145, 4835, 10.1210/en.2004-1028 Goldblum, 1993, TNF-alpha induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction, Am. J. Physiol.-Cell Physiol., 264, C894, 10.1152/ajpcell.1993.264.4.C894 Serin, 2002, Predictive value of tumor necrosis factor alpha (TNF-α) in preeclampsia, Eur. J. Obstet. Gynecol. Reprod. Biol., 100, 143, 10.1016/S0301-2115(01)00484-5 Kohno, 1995, Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells, Hypertension, 25, 1185, 10.1161/01.HYP.25.6.1185 Saleem, 2014, A prospective study of maternal, fetal and neonatal deaths in low-and middle-income countries, Bull. World Health Organ., 92, 605, 10.2471/BLT.13.127464 Poon, 2014, Early prediction of preeclampsia, Obstet. Gynecol. Int., 2014, 10.1155/2014/297397 Tan, 2018, Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation, Ultrasound Obstet. Gynecol., 10.1002/uog.19112 Garayoa, 2000, Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis, Mol. Endocrinol., 14, 848, 10.1210/mend.14.6.0473